FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS

被引：0

作者：

Gugliotta, G. ^{[1
]}

Castagnetti, F. ^{[1
]}

Breccia, M. ^{[2
]}

Levato, L. ^{[3
]}

Fava, C. ^{[4
]}

Luciano, L. ^{[5
]}

Zaccaria, A. ^{[6
]}

Rossi, A. Russo ^{[7
]}

Usala, E. ^{[8
,9
]}

Gozzini, A. ^{[10
]}

Vigneri, P. ^{[11
]}

Cedrone, M. ^{[12
]}

Tiribelli, M. ^{[13
,14
]}

Abruzzese, E. ^{[15
]}

Avanzini, P. ^{[16
]}

Palandri, F. ^{[1
]}

Soverini, S. ^{[1
]}

Alimena, G. ^{[2
]}

Pane, F. ^{[5
]}

Martinelli, G. ^{[1
]}

Cavo, M. ^{[1
]}

Saglio, G. ^{[4
]}

Baccarani, M. ^{[17
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Dept Hematol, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Div Internal Med Hematol, Turin, Italy

[5] Univ Naples Federico II, Dept Hematol CEINGE & Adv Biotechonolgies, Naples, Italy

[6] IRST IRCCS, Hematol Unit, Meldola, Forli Cesena, Italy

[7] Univ Bari, Dept Emergency & Organ Transplantat, Hematol Unit, Bari, Italy

[8] Armando Businco Hosp, Cagliari, Italy

[9] Armando Businco Hosp, Bone Marrow Transplantat Unit, Cagliari, Italy

[10] Univ Florence, Careggi Hosp, Dept Hematol, Florence, Italy

[11] Univ Catania, Ferrarotto Hosp, Div Hematol, Catania, Italy

[12] San Giovanni Hosp, Hematol Unit, Rome, Italy

[13] Univ Udine, Dept Expt & Clin Med Sci, Div Hematol, I-33100 Udine, Italy

[14] Univ Udine, Dept Expt & Clin Med Sci, I-33100 Udine, Italy

[15] S Eugenio Hosp, Dept Hematol, Rome, Italy

[16] Santa Maria Nuova Hosp, Hematol Unit, Reggio Emilia, Italy

[17] Univ Bologna, Bologna, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P892

引用

页码：333 / 333

页数：1

共 50 条

[31] CONTINUED SUPERIORITY OF NILOTINIB VS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTND BEYOND 1 YEAR
Hochhaus, A.
Lobo, C.
Pasquini, R.
Clark, R.
Kim, D. W.
Issaragrisil, S.
le Coutre, P.
Reiffers, J.
Kantarjian, H.
Saglio, G.
Edrich, P.
Hoenekopp, A.
Gallagher, N.
Larson, R.
Hughes, T.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 459 - 459
[32] CHROMOSOMAL ABNORMALITIES IN PHILADELPHIA CHROMOSOME (PH)-NEGATIVE METAPHASES IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC FRONTLINE WITH NILOTINIB OR DASATINIB
Shah, S.
Kantarjian, H.
O'Brien, S.
Borthakur, G.
Burger, J.
Kadia, T.
Pemmaraju, N.
DiNardo, C.
Jabbour, E.
Cortes, J.
HAEMATOLOGICA, 2014, 99 : 337 - 337
[33] Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Saydam, Guray
Haznedaroglu, Ibrahim Celalettin
Kaynar, Leylagul
Yavuz, Akif S.
Ali, Ridvan
Guvenc, Birol
Akay, Olga M.
Baslar, Zafer
Ozbek, Ugur
Sonmez, Mehmet
Aydin, Demet
Pehlivan, Mustafa
Undar, Bulent
Dagdas, Simten
Ayyildiz, Orhan
Akkaynak, Diyar Z.
Dag, Ilkiz M.
Ilhan, Osman
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (14) : 1851 - 1858
[34] Impact of age in the outcome of patients with chronic myeloid leukemia in late chronic phase: Clinical and molecular results of a phase II study of the GIMEMA CML working party.
Martinelli, Giovanni
Palandri, Francesca
Iacobucci, Ilaria
Bassi, Simona
Castagnetti, Fausto
Amabile, Marilina
Cilloni, Daniela
Poerio, Angela
Soverini, Simona
Rege-Cambrin, Giovanna
Iuliano, Franco
Alimena, Giuliana
Latagliata, Roberto
Testoni, Nicoletta
Pane, Fabrizio
Saglio, Giuseppe
Rosti, Gianantonio
Baccarani, Michele
BLOOD, 2006, 108 (11) : 286B - 286B
[35] Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial
Breccia, Massimo
Castagnetti, Fausto
Gugliotta, Gabriela
Martino, Bruno
Rossi, Giuseppe
Carella, Angelo Michele
Stagno, Fabio
Turri, Diamante
Avanzini, Paolo
Trabacchi, Elena
Pierri, Ivana
Tiribelli, Mario
Isidori, Alessandro
Salvucci, Marzia
Capalbo, Silvana
Merli, Anna
Levato, Luciano
Binotto, Gianni
Maino, Elena
Rupoli, Serena
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Alimena, Giuliana
Rosti, Gianantonio
BLOOD, 2015, 126 (23)
[36] LONG-TERM (10-YEAR) OUTCOME OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH NILOTINIB 400 BID IN FIRST-LINE: FINAL RESULTS OF THE GIMEMA CML 0307 STUDY
Gugliotta, G.
Castagnetti, F.
Breccia, M.
Levato, L.
Intermesoli, T.
D'Adda, M.
Salvucci, M.
Stagno, F.
Cambrin, G. Rege
Tiribelli, M.
Martino, B.
Bocchia, M.
Cedrone, M.
Trabacchi, E.
Cavazzini, F.
Porretto, F.
Sora, F.
Usala, E.
Albano, F.
Martinelli, G.
Soverini, S.
Foa, R.
Pane, F.
Cavo, M.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2019, 104 : 146 - 146
[37] Comparison of the Outcome between Newly Diagnosed Patients in the Accelerated Phase and Chronic Phase with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors
Jiang, Qian
Yu, Lu
Qin, Ya-Zhen
Lai, Yue-Yun
Huang, Xiao-Jun
BLOOD, 2017, 130
[38] LONG TERM OUTCOME OF 559 PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONT-LINE WITH IMATINIB: 5-YEAR RESULTS OF 3 INDEPENDENT STUDIES OF THE GIMEMA CML WORKING PARTY
Castagnetti, F.
Palandri, F.
Gugliotta, G.
Breccia, M.
Specchia, G.
Abruzzese, E.
Levato, L.
Intermesoli, T.
Martino, B.
Pregno, P.
Orlandi, E.
Iacobucci, I.
Soverini, S.
Testoni, N.
Alimena, G.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 54 - 54
[39] Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in ehronic phase (CML-CP): ENESTnd beyond one year
Larson, R. A.
le Coutre, P. D.
Reiffers, J.
Hughes, T. P.
Saglio, G.
Edrich, P.
Hoenekopp, A.
Gallagher, N. J.
Kantarjian, H.
Hochhaus, A.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[40] Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis
Berdeja, Jesus G.
Heinrich, Michael C.
Dakhil, Shaker R.
Goldberg, Stuart L.
Wadleigh, Martha
Kuriakose, Philip
Cortes, Jorge
Radich, Jerald
Helton, Bret
Rizzieri, David
Paley, Carole
Dautaj, Ilva
Mauro, Michael J.
LEUKEMIA & LYMPHOMA, 2019, 60 (10) : 2384 - 2393

← 1 2 3 4 5 →